Literature DB >> 4280909

Endogenous steroid concentrations in human breast tumours determined by high-resolution mass fragmentography.

D Millington, D A Jenner, T Jones, K Griffiths.   

Abstract

A pilot study of the endogenous steroid concentrations in human breast tumours was performed. The technique of high-resolution molecular-ion monitoring during combined g.l.c.-mass spectrometry was used to determine oestrone, oestradiol-17beta and oestriol in concentrations above 1ng/g wet wt. of tissue, and dehydroepiandrosterone, testosterone, androsterone (3alpha-hydroxy-5alpha-androstan-17-one) and 3beta-hydroxy-5alpha-androstan-17-one in concentrations exceeding 5ng/g, in extracts of five primary breast tumours.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4280909      PMCID: PMC1166305          DOI: 10.1042/bj1390473

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  5 in total

1.  Estrogen receptors in human breast cancer tissue.

Authors:  H Maass; B Engel; H Hohmeister; F Lehmann; G Trams
Journal:  Am J Obstet Gynecol       Date:  1972-06-01       Impact factor: 8.661

2.  Quantitation of up to 12 estrogens in 1-50 l of pregnancy urine.

Authors:  H Adlercreutz; D H Hunneman
Journal:  J Steroid Biochem       Date:  1973-03       Impact factor: 4.292

3.  Specific binding of oestradiol in human uterine tissue.

Authors:  G Trams; B Engel; F Lehmann; H Maass
Journal:  Acta Endocrinol (Copenh)       Date:  1973-02

4.  Mass fragmentographic analysis of steroids, catecholamines, and amino acids in biological materials.

Authors:  B F Maume; P Bournot; J C Lhuguenot; C Baron; F Barbier; G Maume; M Prost; P Padieu
Journal:  Anal Chem       Date:  1973-06       Impact factor: 6.986

5.  Oestrogen receptor in human breast cancer tissue and response to endocrine therapy.

Authors:  E Engelsman; J P Persijn; C B Korsten; F J Cleton
Journal:  Br Med J       Date:  1973-06-30
  5 in total
  2 in total

Review 1.  Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.

Authors:  P E Lønning; S Kvinnsland
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

Review 2.  Treatment of breast cancer with aromatase inhibitors--current status and future prospects.

Authors:  P E Lønning; M Dowsett; T J Powles
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.